DrugPatentWatch Database Preview
Drugs in Development Information for PBT-1033
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug PBT-1033?
PBT-1033 is an investigational drug.
There have been 5 clinical trials for PBT-1033.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Esophageal Neoplasms, Adenocarcinoma, and Lung Neoplasms. The leading clinical trial sponsors are NRG Oncology, National Cancer Institute (NCI), and Mayo Clinic.
Summary for PBT-1033
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2008-02-01) |
| Vendors | 9 |
Recent Clinical Trials for PBT-1033
| Title | Sponsor | Phase |
|---|---|---|
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | National Cancer Institute (NCI) | Phase 3 |
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | NRG Oncology | Phase 3 |
| Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy | xjpfW | N/A |
Clinical Trial Summary for PBT-1033
Top disease conditions for PBT-1033
Top clinical trial sponsors for PBT-1033
US Patents for PBT-1033
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
